Rhett blood glucose monitoring system
Taiwan·Risk Class 2·Daqing Factory of Huaguang Biotechnology Co., Ltd·Registered Aug 26, 2020 – Aug 26, 2025Expired- Analysis ID
- 12b016567bc30e64524831853ae9afe5
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Daqing Factory of Huaguang Biotechnology Co., Ltd
- Intended Use
- This product is specially designed for in vitro diagnostics, which can be used by professionals to detect the blood glucose values of microvascular whole blood and veins, arteries and neonatal whole blood collected from fingertips, palms or arms.
- Product Type (Level 1)
- A Clinical Chemistry and Clinical Toxicology;; I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical); I.4800 Surgical Hand Instruments for General Surgery;; A.1345 Glucose test system
- Import Information
- QMS/QSD;; 國產
- Registration Date
- Aug 26, 2020
- Expiry Date
- Aug 26, 2025
Top companies providing products similar to "Rhett blood glucose monitoring system"
Recently registered similar products
Access comprehensive regulatory information for Rhett blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 12b016567bc30e64524831853ae9afe5 and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Daqing Factory of Huaguang Biotechnology Co., Ltd, and 5 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.